View in EDS HTML Full Text PDF Full Text

Systemic administration of IL-33 induces a population of circulating KLRG1hi type 2 innate lymphoid cells and inhibits type 1 innate immunity against multiple myeloma.

Saved in:
Bibliographic Details
Title: Systemic administration of IL-33 induces a population of circulating KLRG1hi type 2 innate lymphoid cells and inhibits type 1 innate immunity against multiple myeloma.
Authors: Guillerey C; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.; School of Medicine, The University of Queensland, Herston, QLD, Australia., Stannard K; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Chen J; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.; School of Medicine, The University of Queensland, Herston, QLD, Australia., Krumeich S; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Miles K; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Nakamura K; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Smith J; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.; School of Environment and Sciences, Griffith University, Brisbane, QLD, Australia., Yu Y; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Ng S; Immunology and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Harjunpää H; School of Medicine, The University of Queensland, Herston, QLD, Australia.; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Teng MW; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Engwerda C; Immunology and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Belz GT; Immunology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, VIC, Australia., Smyth MJ; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.; School of Medicine, The University of Queensland, Herston, QLD, Australia.
Source: Immunology and cell biology [Immunol Cell Biol] 2021 Jan; Vol. 99 (1), pp. 65-83. Date of Electronic Publication: 2020 Sep 18.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 8706300 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1440-1711 (Electronic) Linking ISSN: 08189641 NLM ISO Abbreviation: Immunol Cell Biol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32748462
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Systemic administration of IL-33 induces a population of circulating KLRG1<superscript>hi</superscript> type 2 innate lymphoid cells and inhibits type 1 innate immunity against multiple myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Guillerey+C%22">Guillerey C</searchLink>; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.; School of Medicine, The University of Queensland, Herston, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Stannard+K%22">Stannard K</searchLink>; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Chen+J%22">Chen J</searchLink>; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.; School of Medicine, The University of Queensland, Herston, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Krumeich+S%22">Krumeich S</searchLink>; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Miles+K%22">Miles K</searchLink>; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Nakamura+K%22">Nakamura K</searchLink>; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Smith+J%22">Smith J</searchLink>; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.; School of Environment and Sciences, Griffith University, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Yu+Y%22">Yu Y</searchLink>; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Ng+S%22">Ng S</searchLink>; Immunology and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Harjunpää+H%22">Harjunpää H</searchLink>; School of Medicine, The University of Queensland, Herston, QLD, Australia.; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Teng+MW%22">Teng MW</searchLink>; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Engwerda+C%22">Engwerda C</searchLink>; Immunology and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Belz+GT%22">Belz GT</searchLink>; Immunology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Smyth+MJ%22">Smyth MJ</searchLink>; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.; School of Medicine, The University of Queensland, Herston, QLD, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228706300%22">Immunology and cell biology</searchLink> [Immunol Cell Biol] 2021 Jan; Vol. 99 (1), pp. 65-83. <i>Date of Electronic Publication: </i>2020 Sep 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8706300 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1440-1711 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208189641%22">08189641 </searchLink><i>NLM ISO Abbreviation: </i>Immunol Cell Biol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32748462
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/imcb.12390
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 65
    Titles:
      – TitleFull: Systemic administration of IL-33 induces a population of circulating KLRG1hi type 2 innate lymphoid cells and inhibits type 1 innate immunity against multiple myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Guillerey C
      – PersonEntity:
          Name:
            NameFull: Stannard K
      – PersonEntity:
          Name:
            NameFull: Chen J
      – PersonEntity:
          Name:
            NameFull: Krumeich S
      – PersonEntity:
          Name:
            NameFull: Miles K
      – PersonEntity:
          Name:
            NameFull: Nakamura K
      – PersonEntity:
          Name:
            NameFull: Smith J
      – PersonEntity:
          Name:
            NameFull: Yu Y
      – PersonEntity:
          Name:
            NameFull: Ng S
      – PersonEntity:
          Name:
            NameFull: Harjunpää H
      – PersonEntity:
          Name:
            NameFull: Teng MW
      – PersonEntity:
          Name:
            NameFull: Engwerda C
      – PersonEntity:
          Name:
            NameFull: Belz GT
      – PersonEntity:
          Name:
            NameFull: Smyth MJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2021 Jan
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1440-1711
          Numbering:
            – Type: volume
              Value: 99
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Immunology and cell biology
              Type: main
ResultId 1